Page 86 - Priority Review News Today

The FDA has accepted for Priority Review the BLA for the SC formulation of efgartigimod for the treatment of generalized myasthenia gravis in adults.

The FDA has accepted for Priority Review the BLA for epcoritamab (DuoBody-CD3xCD20) to treat relapsed/refractory large B-Cell lymphoma (LBCL).

/PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Hemgenix (etranacogene dezaparvovec), an adeno-associated virus vector-based gene therapy...

On November 17, 2022, the US Food and Drug Administration (FDA) approved a pathbreaking new drug called Tzield. This injectable formulation contains a combination of two drugs that could push back the onset of type 1 diabetes (T1D) in adults at stage 3 and children aged eight years or more at stage 2.

(RTTNews) - The U.S. Food and Drug Administration said it has approved Provention Bio Inc.s Tzield (teplizumab-mzwv) injection to delay the onset...

The FDA has approved the first drug to help delay the onset of stage 3 type 1 diabetes in patients over eight with stage 2 type 1 diabetes.

/PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Tzield (teplizumab-mzwv) injection to delay the onset of stage 3 type 1 diabetes in...

/PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Tzield (teplizumab-mzwv) injection to delay the onset of stage 3 type 1 diabetes in...

For UK Trade and Medical Media Only Rezafungin is a novel, once-weekly echinocandin being developed for both the treatment and prevention of serious fungal infections The Medicines and

After decades of false starts, a vaccine for respiratory syncytial virus may finally be within reach.